anonymous
Guest
anonymous
Guest
We are speaking up but then have a team meeting about Glint survey. It’s the HQ leadership not the people actually doing the work that is the problem. Look at executive directors first. Put the right leaders who really care and listen to their people. You hear the rumblings about who the good leaders are. Follow those insights. If things don’t improve replace the Executive Directors and see the domino effect of progress sooner. Otherwise, we can keep doing this circus. Secondly, there are too many executive directors in IMO. We don’t need them. We have smart people at Novartis who can get the work done.